文献速递类风湿关节炎

早期未治疗类风湿关节炎循环与滑膜免疫细胞的比较分析及其与分子病理和疾病结局的关系

Comparative Analysis of Circulating and Synovial Immune Cells in Early Untreated Rheumatoid Arthritis and Their Relationship With Molecular Pathology and Disease Outcomes.
PubMed 文献 · Arthritis Rheumatol · 2025-07-07

该事后分析纳入早期(<12个月)未治疗类风湿关节炎患者144例,行超声引导滑膜活检并按滑膜病理分型,外周血70例行流式细胞术,滑膜组织144例及配对血55例行RNA测序特征反卷积分析。结果显示循环Tph细胞与全身及局部炎症标志物正相关,滑膜特征与临床结局相关,6个月缓解者基线滑膜Tph特征更高且治疗后下降更大。

要点

  • 循环Tph细胞与血沉、C反应蛋白及超声滑膜增厚、滑膜炎评分均正相关。
  • 血清阳性及淋巴髓系滑膜炎患者循环Tph细胞显著更高。
  • 6个月缓解者基线滑膜Tph特征更高且治疗后下降更大。

核心结论

  • 早期未治疗类风湿关节炎患者滑膜与外周血免疫细胞特征存在差异,两处的Tph细胞均为炎症、疾病活动度和治疗反应的关键标志物。

研究设计与样本

  • 来自早期关节炎病理生物学队列的早期(<12个月)未治疗类风湿关节炎患者144例纳入本项事后分析,行超声引导下最活跃关节滑膜活检后接受标准治疗并观察12个月。
  • 滑膜活检行免疫组化并分类为滑膜病理类型,外周血样本70例行流式细胞术,滑膜组织144例及配对血55例行RNA测序特征反卷积分析。

主要发现

  • 流式细胞术识别的Tph细胞是唯一与全身炎症标志物(血沉、C反应蛋白)及局部炎症(超声滑膜增厚、滑膜炎评分)均正相关的循环免疫细胞亚群。
  • 循环Tph细胞在血清阳性患者及淋巴髓系滑膜炎患者中显著更高,循环B细胞与炎症标志物、超声评分及疾病活动度呈显著负相关。
  • 配对滑膜与外周血的特征反卷积识别出不同的免疫细胞特征,外周血特征与纵向结局无关联,而滑膜特征与临床结局相关。
  • 6个月达到缓解(28关节疾病活动度评分<2.6)的患者基线滑膜Tph特征更高,且治疗后Tph特征下降幅度更大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the relationship of circulating and synovial immune cells with synovial molecular pathology and disease outcomes in patients with early rheumatoid arthritis (RA). METHODS: Patients with early (<12 months) treatment-naive RA (n = 144) from the Pathobiology of Early Arthritis Cohort were included in this post hoc analysis. Following ultrasound (US)-guided synovial biopsy of the most active joint, patients received standard of care treatment and were observed for 12 months. Synovial biopsies were analyzed by immunohistochemistry and classified into synovial pathotypes. Peripheral blood (PB) samples (n = 70) underwent flow cytometry, whereas RNA sequencing from synovial tissue (n = 144) and matched PB (n = 55) were analyzed using signature-based deconvolution. RESULTS: T peripheral helper cells (Tph) cells, identified by flow cytometry, were the only circulating immune cell subset positively correlated with both systemic markers of inflammation (erythrocyte sedimentation rate and C-reactive protein) and local inflammation (US synovial thickening and synovitis score). Circulating Tph cells were also significantly higher in patients who were seropositive and patients with lymphomyeloid synovitis. Conversely, circulating B cells showed a significant inverse correlation with markers of inflammation, US scores, and disease activity. Signature-based deconvolution of matched synovial and PB identified divergent immune cell signatures. Although PB signatures showed no associations with longitudinal outcomes, synovium signatures were linked to clinical outcomes. In particular, patients achieving remission at six months (Disease Activity Score in 28 joints < 2.6) had higher baseline synovial Tph signatures and a greater posttreatment reduction of the Tph signature. CONCLUSION: Patients with early untreated RA showed divergent immune cell signatures between synovia and PB. Tph cells, in both compartments, emerged as key markers for inflammation, disease activity, and treatment response.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Rivellese F, Pontarini E, Fossati-Jimack L, et al. Comparative Analysis of Circulating and Synovial Immune Cells in Early Untreated Rheumatoid Arthritis and Their Relationship With Molecular Pathology and Disease Outcomes. Arthritis Rheumatol. 2025. PMID: 40289062. doi:10.1002/art.43194

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。